Related references
Note: Only part of the references are listed.microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
Xueqiao Jiao et al.
CELLS (2020)
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
Zhaolin Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Noncoding RNAs in gastric cancer: implications for drug resistance
Ling Wei et al.
MOLECULAR CANCER (2020)
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Li Yuan et al.
MOLECULAR CANCER (2020)
Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis
Guo Qingzhi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Prediction of platinum-resistance patients of gastric cancer using bioinformatics
Jiaomeng Pan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
Dong Fu et al.
AGING-US (2019)
PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression
Jianmin Sun et al.
CELL DEATH & DISEASE (2019)
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Hua Guo et al.
CANCER CELL INTERNATIONAL (2019)
First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
Ji Cheng et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer
Jie Li et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4
Yue Fu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
Yanan Wang et al.
CELL DEATH & DISEASE (2018)
Long noncoding RNAs as biotargets in cisplatin-based drug resistance
Nadiah Abu et al.
FUTURE ONCOLOGY (2018)
MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells
Weimin Zhu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation
Yingcong Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1
Tinghui Jiang et al.
ONCOLOGY RESEARCH (2017)
Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3
Yin-ling Xiu et al.
ONCOTARGET (2017)
Chemotherapy for advanced gastric cancer
Anna Dorothea Wagner et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers
Haiyu Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp
Chaojing Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells
Xing-dong Xiong et al.
DRUG RESISTANCE UPDATES (2016)
Advanced gastric cancer: Current treatment landscape and future perspectives
Antonia Digklia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction A Meta-Analysis
Lei Jiang et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
Y. Shang et al.
ONCOGENE (2014)
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters
Qiong Wu et al.
ONCOTARGET (2014)
miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells
Yue Fang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in The Netherlands
A. E. Dassen et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2)
Xiangsheng Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Endometrial miR-181a and miR-98 Expression Is Altered during Transition from Normal into Cancerous State and Target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3
Harekrushna Panda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Whole-genome reconstruction and mutational signatures in gastric cancer
Niranjan Nagarajan et al.
GENOME BIOLOGY (2012)
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention
Siddavaram Nagini
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb et al.
MOLECULAR CANCER (2011)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
N. M. Alajez et al.
CELL DEATH & DISEASE (2010)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Share Paper
